The HSE Annual report and financial statements describe the performance and operation of the Health Service Executive during 2024. It has been prepared according to legislative requirements. The report is not only an instrument of accountability but also information about the delivery of a nationwide health and social care service.

P.26 3.2.4 Social Inclusion
a. Emerging Drug Trends Laboratory: A new laboratory officially opened in the National Drug Treatment Centre, Dublin, to improve monitoring and response to new drug trends. In 2024, over 200 samples were analysed at four festivals, and three health risk communications were issued.
b. Harm reduction responses: Ireland’s first medically supervised injecting facility opened at Merchant’s Quay Ireland; the Circle programme was established to train peers nationally in overdose recognition and naloxone administration (411 administrations of naloxone were recorded in 2024); the HSE’s first addiction services, specifically for people experiencing problem gambling and gaming, were piloted in Limerick, Galway and North Dublin

P.23 Alcohol prevention and early intervention: 28,884 people completed the online alcohol self-assessment tool. A project Echo Community of Practice was established for Integrated Alcohol Services providing psychosocial and therapeutic interventions and family support for people with alcohol use disorders and developing integrated care pathways between acute, primary care and social inclusion services.

P.24 Public health legislation: Continued to implement and inform the development of key environmental/public health legislation, including enforcement of newly enacted provisions of the Public Health (Alcohol) Act 2018 and Public Health (Tobacco and Nicotine Inhaling Products) Act 2023 and planned for the commencement of additional sections of these statutory instruments.
b. Statutory programmes: Risk-based control programmes were delivered in relation to food safety, sunbeds, alcohol, port health, cosmetic products, tobacco, e-cigarettes and import/ export controls, including 53,669 inspections, 16,131 samples, 8,375 investigations and 73,293 import/export actions.

Appendix 1 – Revenue Grants and Capital Grants (funded organisations)